Correlation Between Diagnostic Nerve Block Response and Cryoneurolysis Outcome in Chronic Musculoskeletal Disorders
CRYONIC
2 other identifiers
interventional
50
0 countries
N/A
Brief Summary
The clinical study is titled the CRYONIC PROTOCOL, which stands for Cryotherapy for Neurolysis In Chronic Pain. It is structured as a prospective, multi-cohort observational study. Purpose of the Study: The overarching purpose of the CRYONIC PROTOCOL study is to assess the Correlation Between Diagnostic Nerve Block Response and Cryoneurolysis Outcome in Chronic Musculoskeletal Disorders. The study focuses on evaluating the effectiveness of ultrasound-guided peripheral nerve cryoneurolysis, a minimally invasive technique that uses extreme cold to induce temporary nerve blocks, for patients with treatment-resistant chronic musculoskeletal pain. The study also seeks to determine if cryoneurolysis itself leads to meaningful improvements in both pain intensity and functional ability in the included patient cohorts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2025
CompletedFirst Posted
Study publicly available on registry
December 17, 2025
CompletedStudy Start
First participant enrolled
July 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2030
Study Completion
Last participant's last visit for all outcomes
August 1, 2031
April 27, 2026
November 1, 2025
3.8 years
December 4, 2025
April 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Numeric Rating Scale (NRS)
Correlation between diagnostic nerve bloc and cryoneurolysis Numeric Rating Scale (NRS) for pain, range 0-10, higher scores indicate worse pain.
3 months
Secondary Outcomes (18)
2-Minute Walk Test (2MWT)
3 months
Timed Up and Go
3 months
Passive Range of Motion
3 months
Goal Attainment Scaling
3 months
Modified Tardieu Scale
3 months
- +13 more secondary outcomes
Study Arms (1)
Chronic musculoskeletal pain group
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Be over 18 year old
- Adults (\> 18y) with either chronic musculoskeletal pain (\> 3 months; average NRS \> 5/10) or painful/functionally limiting spasticity
- Have a clinical stable condition, \> 3months
- Any medications must be maintained on a stable schedule- Able to understand study instructions and provide informed consent (ICF) in French or Dutch.Provide written informed consent
You may not qualify if:
- Contraindication to cryoneurolysis such as a diagnosis of cryoglobulinemia, paroxysmal cold haemoglobinuria, cold urticaria, Raynaud's disease, any form of peripheral neuropathy, open and or infected wounds of the affected limb
- Patient's refusal to give consent to the procedure or to use of their data for research purposes.
- Ongoing local or systemic infection before the procedure.
- Predominantly neuropathic pain of the upper extremity as assessed with the Pain Detect questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2025
First Posted
December 17, 2025
Study Start (Estimated)
July 1, 2026
Primary Completion (Estimated)
May 1, 2030
Study Completion (Estimated)
August 1, 2031
Last Updated
April 27, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share